Los Angeles, CA
United States
Cedars Sinai Medical Center - Division of Medical Oncology
COVID-19, SARS-CoV-2, Cancer, Immune Checkpoint Inhibitors, B-Cell Targeted Therapies, Humoral Immune Response, Breakthrough Infections
non-small cell lung cancer, DNA damage repair, Genomics, biomarkers, tumor immune microenvironment